NEPTUNE Match Study

Launched by UNIVERSITY OF MICHIGAN · Sep 25, 2020

Keywords

ClinConnect Summary

This is a prospective, open-label study testing the ability to effectively communicate patient-specific clinical trial matching with kidney patients and clinician investigators. The study consists of four components:

1. Recruitment of participants from the NEPTUNE observational cohort study
2. Generation of participant profile-trial match assessment using data from the NEPTUNE observational study and profiling units by the NEPTUNE Molecular Nephrology Board
3. Establishing and testing a framework to communicate disease-trial drug mechanism matching with investigators and patients
4. Retros...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Consented and eligible participants in the biopsied or non-biopsied cohorts of the NEPTUNE observational study
• • 2. Must be potentially eligible for the NEPTUNE Match partnering trials (e.g. if no trial is enrolling a participant under age 6, those under 6 are not eligible).
• • Note: NEPTUNE Match partnering trials and associated eligibility criteria are expected to be dynamic and change as trial protocols are developed, activated, and amended.
• • 3. Regular nephrology healthcare provided at a NEPTUNE study site.
• • 4. Willing and able to consent, and as appropriate assent, to participate in NEPTUNE Match
• Exclusion Criteria:
• • Currently non-NEPTUNE observational study participants are not eligible to be matched to a clinical trial using these biomarker assessments.
• Exclusion Criteria:
• • 1. Non-English or non-Spanish speaking